BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6939922)

  • 1. Quantitative comparison of covalent aflatoxin-DNA adducts formed in rat and mouse livers and kidneys.
    Croy RG; Wogan GN
    J Natl Cancer Inst; 1981 Apr; 66(4):761-8. PubMed ID: 6939922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excision repair of aflatoxin B1-DNA adducts in human fibroblasts.
    Leadon SA; Tyrrell RM; Cerutti PA
    Cancer Res; 1981 Dec; 41(12 Pt 1):5125-9. PubMed ID: 6796265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aflatoxin-albumin adducts: a basis for comparative carcinogenesis between animals and humans.
    Wild CP; Hasegawa R; Barraud L; Chutimataewin S; Chapot B; Ito N; Montesano R
    Cancer Epidemiol Biomarkers Prev; 1996 Mar; 5(3):179-89. PubMed ID: 8833618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal patterns of covalent DNA adducts in rat liver after single and multiple doses of aflatoxin B1.
    Croy RG; Wogan GN
    Cancer Res; 1981 Jan; 41(1):197-203. PubMed ID: 7448760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The reactivity and carcinogenicity of aflatoxin B1-2,3-dichloride, a model for the putative 2,3-oxide metabolite of aflatoxin B1.
    Swenson DH; Miller JA; Miller EC
    Cancer Res; 1975 Dec; 35(12):3811-23. PubMed ID: 1104159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative and qualitative characterization of aflatoxin B1 adducts formed in vivo within the ribosomal RNA genes of rat liver DNA.
    Irvin TR; Wogan GN
    Cancer Res; 1985 Aug; 45(8):3497-502. PubMed ID: 3926300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural characterization of the major adducts obtained after reaction of an ultimate carcinogen aflatoxin B1-dichloride with calf thymus DNA in vitro.
    Wood ML; Smith JR; Garner RC
    Cancer Res; 1988 Oct; 48(19):5391-6. PubMed ID: 3138022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Food restriction reduces aflatoxin B1 (AFB1)-DNA adduct formation, AFB1-glutathione conjugation, and DNA damage in AFB1-treated male F344 rats and B6C3F1 mice.
    Chou MW; Chen W
    J Nutr; 1997 Feb; 127(2):210-7. PubMed ID: 9039820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2,3-Dihydro-2-(guan-7-yl)-3-hydroxy-aflatoxin B1, a major acid hydrolysis product of aflatoxin B1-DNA or -ribosomal RNA adducts formed in hepatic microsome-mediated reactions and in rat liver in vivo.
    Lin JK; Miller JA; Miller EC
    Cancer Res; 1977 Dec; 37(12):4430-8. PubMed ID: 922734
    [No Abstract]   [Full Text] [Related]  

  • 11. Species susceptibility to aflatoxin B1 carcinogenesis: comparative kinetics of microsomal biotransformation.
    Ramsdell HS; Eaton DL
    Cancer Res; 1990 Feb; 50(3):615-20. PubMed ID: 2105159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological detection of aflatoxin B1-DNA adducts formed in vivo.
    Hsieh LL; Hsu SW; Chen DS; Santella RM
    Cancer Res; 1988 Nov; 48(22):6328-31. PubMed ID: 3141043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of sex difference on the in vitro and in vivo metabolism of aflatoxin B1 by the rat.
    Gurtoo HL; Motycka L
    Cancer Res; 1976 Dec; 36(12):4663-71. PubMed ID: 1000509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of schistosomiasis on the activation of aflatoxin B1.
    Hasler JA; Siwela AH; Nyathi CB; Chetsanga CJ
    Res Commun Chem Pathol Pharmacol; 1986 Mar; 51(3):421-4. PubMed ID: 3085178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro biotransformation and genotoxicity of the drinking water disinfection byproduct bromodichloromethane: DNA binding mediated by glutathione transferase theta 1-1.
    Ross MK; Pegram RA
    Toxicol Appl Pharmacol; 2004 Mar; 195(2):166-81. PubMed ID: 14998683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Removal of aflatoxin B1-DNA adducts and in vitro transformation in mouse embryo fibroblasts C3H/10T1 1/2.
    Amstad PA; Wang TV; Cerutti PA
    J Natl Cancer Inst; 1983 Jan; 70(1):135-9. PubMed ID: 6401827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of covalent aflatoxin B1-DNA adducts formed in vivo in rainbow trout (Salmo gairdneri) embryos and liver.
    Croy RG; Nixon JE; Sinnhuber RO; Wogan GN
    Carcinogenesis; 1980; 1(11):903-9. PubMed ID: 11219843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the principal aflatoxin B1-DNA adduct formed in vivo in rat liver.
    Croy RG; Essigmann JM; Reinhold VN; Wogan GN
    Proc Natl Acad Sci U S A; 1978 Apr; 75(4):1745-9. PubMed ID: 273905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of aflatoxin B1 binding to DNA in vivo in rats fed phenolic antioxidants, ethoxyquin and a dithiothione.
    Kensler TW; Egner PA; Trush MA; Bueding E; Groopman JD
    Carcinogenesis; 1985 May; 6(5):759-63. PubMed ID: 3924431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1,3-butadiene: cancer, mutations, and adducts. Part IV: Molecular dosimetry of 1,3-butadiene.
    Blair IA; Oe T; Kambouris S; Chaudhary AK
    Res Rep Health Eff Inst; 2000 Mar; (92):151-90; discussion 211-9. PubMed ID: 10925841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.